Global /China /Healthcare /Drug Manufacturers - General /688117

ChengDu ShengNuo Biotec Co.,Ltd.

688117

• SSE: 688117 • Delayed

37.41CNY 0.5%

5.53 USD

As of 14 June 2026, ChengDu ShengNuo Biotec Co.,Ltd. has a market cap of $864.97M USD, ranking #11580 globally and #3363 in China. It ranks #1050 in the Healthcare sector, and #395 in the Drug Manufacturers - General industry.

Global Rank

11580

Country Rank

3363

Sector Rank

1050

Industry Rank

395

Key Stats

Market Cap

$864.97MUSD

5.86B CNY

Enterprise Value

$907.25MUSD

6.14B CNY

Revenue (TTM)

$118.27MUSD

801.4M CNY

EBITDA (TTM)

$47.64MUSD

322.37M CNY

Net Income (TTM)

$26.15MUSD

177.17M CNY

EBITDA Margin

40%

Profit Margin

22%

PE Ratio

33.2

Forward PE

21.7

PS Ratio

7.3

PB Ratio

5.2

EV/EBITDA

19.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Yongjun Wen open_in_new

Employees

1,450

Founded

2001

Website

snbiopharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.5%	-2%	10%	-5.2%	-7.4%	-1.5%	73%	129%	20%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688117 成都圣诺生物科技股份有限公司 Class A ISIN: CNE1000051M8 Shares Out.: Shares Outstanding: 220.34M¹ Shares Float: 220.33M² TV: TradingView: SSE: 688117 SA: Stock Analysis: SHA: 688117 YF: Yahoo Finance: 688117.SS GF: Google Finance: SHA: 688117 BA: Barron's: 688117 MS: Morningstar: XSHG: 688117	37.41 CNY	TV: TradingView: SSE: 688117 SA: Stock Analysis: SHA: 688117 YF: Yahoo Finance: 688117.SS GF: Google Finance: SHA: 688117 BA: Barron's: 688117 MS: Morningstar: XSHG: 688117

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About ChengDu ShengNuo Biotec Co.,Ltd.

ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company offers semaglutide, tirzepatide, retatrutide, cagrilintide, lanreotide, bivalirudin, epitifibatide, liraglutide; icatibant, octreotide, teriparatide, ziconotide, ganirelix, linaclotide, abaloparatide, terlipressin acetate; levosimendane, thymosin alpha, enfuvirtide, somatostatin, thymopentin, carbetocin, atosiban acetate, exenatide; and leuprorelin, degarelix, cetrorelix, plecanatide, and desmopressin acetate. ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 6K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 6K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 88K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 63K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 42K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 37K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 33K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 32K%	20.5	Switzerland

chevron_leftBack